ACCU-CHECK FastClix Lancing Device. It is intended for use in conjunction with a blood glucose monitoring system.
Published September 4, 2013 · Recall initiated: August 19, 2013
Summary
FDA records medical device Class II recall Z-2109-2013, published September 4, 2013 and initiated August 19, 2013. Recalling firm: Roche Diagnostics Operations, Inc.; Status: Terminated; Reported quantity: 36,332; Lot: Lot Number(s): GDA 048, GDA050, GDA 051, GDA 063. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Internal Roche inspections have revealed that after the lancet is used for a finger stick, the needle may not fully retract back within the lancet drum or back into the cap. This allows the needle to protrude inside the cap or outside of the cap of the ACCU-CHEK FastClix lancing device.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Roche Diagnostics Operations, Inc.
- Distributor
- Nationwide Distribution
- Lot
- Lot Number(s): GDA 048, GDA050, GDA 051, GDA 063
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United States
Related recalls
- FDAcobas HCYS, Homocysteine Enzymatic Assay, Material Number REF 06542921190, for use on cobas c 701/702, inNovember 27, 2024
- FDACreatine Kinase (CK) used on cobas c 311/501/502 and COBAS INTEGRA 400 plus-In vitro test for the quantitativeOctober 2, 2024
- FDAAlbumin Gen.2, Catalog 05166861190October 21, 2020
- FDAElecsys Anti-HAV IgM assay-for the in vitro qualitative detection of IgM antibodies to hepatitis A virusDecember 18, 2019
- FDAAxiom Artis systems. C-arm angiographic x-ray system x-ray, angiographic system.September 4, 2013
- FDAPrepStain AG. For use in the screening and detection of cervical cancer.September 4, 2013
Questions about this recall
Was ACCU-CHECK FastClix Lancing Device. It is intended for use in conjunction with a blood glucose monitoring system. recalled?
Yes. FDA published recall Z-2109-2013 on September 4, 2013. Reported hazard: Internal Roche inspections have revealed that after the lancet is used for a finger stick, the needle may not fully retract back within the lancet drum or back into the cap. This allows the needle to protrude inside the cap or outside of the cap of the ACCU-CHEK FastClix lancing device.
What should I do if I have this product?
Voluntary: Firm initiated · Letter